Financial reports
Current reports
8-K
Tibet Pharmaceuticals, Inc. Announces Receipt of Non-Binding “Going Private” Proposal at $3.00 Per Share
1 Mar 12
8-K
Departure of Directors or Certain Officers
18 Jan 12
8-K
Tibet Pharmaceuticals Announces Appointment of Sherb & Co., LLP as New Independent Auditor
18 Oct 11
8-K
Tibet Pharmaceuticals Announces Search for New Auditor Upon Resignation of ACSB
12 Sep 11
8-K
Changes in Control of Registrant
10 Jun 11
8-K
Other Events
27 Apr 11
8-K
Other Events
25 Apr 11
Registration and prospectus
25-NSE
Exchange delisting
9 May 12
8-A12B/A
Registration of securities on exchange (amended)
21 Jan 11
424B3
Prospectus supplement
18 Jan 11
8-A12B
Registration of securities on exchange
18 Jan 11
S-1/A
IPO registration (amended)
16 Dec 10
S-1/A
IPO registration (amended)
6 Dec 10
S-1/A
IPO registration (amended)
23 Nov 10
S-1/A
IPO registration (amended)
4 Nov 10
S-1/A
IPO registration (amended)
27 Oct 10
S-1/A
IPO registration (amended)
22 Oct 10
Proxies
No filings